Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid

Min Pan(St. Jude Children's Research Hospital), Paul Geeleher(St. Jude Children's Research Hospital), Shondra M. Pruett‐Miller(St. Jude Children's Research Hospital), Heather Sheppard(St. Jude Children's Research Hospital), Michael A. Dyer(St. Jude Children's Research Hospital), Duane Currier(St. Jude Children's Research Hospital), John Easton(St. Jude Children's Research Hospital), Lei Yang(St. Jude Children's Research Hospital), Brian J. Abraham(Whitehead Institute for Biomedical Research), Jon P. Connelly(St. Jude Children's Research Hospital), Yinwen Zhang(St. Jude Children's Research Hospital), Burgess B. Freeman(St. Jude Children's Research Hospital), Richard H. Chapple(St. Jude Children's Research Hospital), Xueying Liu(St. Jude Children's Research Hospital), Selene C. Koo(St. Jude Children's Research Hospital), Meifen Lu(St. Jude Children's Research Hospital), William C. Wright(St. Jude Children's Research Hospital), George E. Campbell(St. Jude Children's Research Hospital), Allister J. Loughran(St. Jude Children's Research Hospital), Bárbara dos Santos Passaia(St. Jude Children's Research Hospital), Emily M. Plyler(St. Jude Children's Research Hospital), Jonathan Low(St. Jude Children's Research Hospital), Elizabeth Stewart(St. Jude Children's Research Hospital), Taosheng Chen(St. Jude Children's Research Hospital), Bensheng Ju(St. Jude Children's Research Hospital), Jacob Steele(St. Jude Children's Research Hospital)

Nature Communications

February 28, 2025

Cited by 5

|Nature|2012|1.6k

|New England Journal of Medicine|2014|1.4k

|New England Journal of Medicine|2015|1.4k

|Nature Genetics|2017|934

|Nature|2012|853

Related Papers